Search

Your search keyword '"Kochupurakkal, Bose"' showing total 76 results
Start Over Author "Kochupurakkal, Bose" Publisher american association for cancer research (aacr)
76 results on '"Kochupurakkal, Bose"'

1. Abstract B005: A phase 1 expansion cohort study evaluating the safety and efficacy of the CHK1 inhibitor LY2880070 with low-dose gemcitabine in metastatic pancreatic adenocarcinoma

Author

Huffman, Brandon M., primary, Feng, Hanrong, additional, Parmar, Kalindi, additional, Wang, Junning, additional, Kapner, Kevin, additional, Kochupurakkal, Bose, additional, Martignetti, David, additional, Abrams, Thomas, additional, Biller, Leah, additional, Giannakis, Marios, additional, Ng, Kimmie, additional, Patel, Anuj, additional, Perez, Kimberly, additional, Singh, Harshabad, additional, Rubinson, Douglas, additional, Schlechter, Benjamin, additional, Andrews, Elizabeth, additional, Hannigan, Alison, additional, Dunwell, Stanley, additional, Getchell, Zoe, additional, Raghavan, Srivatsan, additional, Wolpin, Brian, additional, D'Andrea, Alan, additional, Aguirre, Andrew, additional, Shapiro, Geoffrey, additional, and Cleary, James, additional

Published
2024
Full Text
View/download PDF

2. Supplementary Figures S1-S2 from A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Huffman, Brandon M., primary, Feng, Hanrong, primary, Parmar, Kalindi, primary, Wang, Junning, primary, Kapner, Kevin S., primary, Kochupurakkal, Bose, primary, Martignetti, David B., primary, Sadatrezaei, Golbahar, primary, Abrams, Thomas A., primary, Biller, Leah H., primary, Giannakis, Marios, primary, Ng, Kimmie, primary, Patel, Anuj K., primary, Perez, Kimberly J., primary, Singh, Harshabad, primary, Rubinson, Douglas A., primary, Schlechter, Benjamin L., primary, Andrews, Elizabeth, primary, Hannigan, Alison M., primary, Dunwell, Stanley, primary, Getchell, Zoe, primary, Raghavan, Srivatsan, primary, Wolpin, Brian M., primary, Fortier, Caroline, primary, D'Andrea, Alan D., primary, Aguirre, Andrew J., primary, Shapiro, Geoffrey I., primary, and Cleary, James M., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table S1 from A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Huffman, Brandon M., primary, Feng, Hanrong, primary, Parmar, Kalindi, primary, Wang, Junning, primary, Kapner, Kevin S., primary, Kochupurakkal, Bose, primary, Martignetti, David B., primary, Sadatrezaei, Golbahar, primary, Abrams, Thomas A., primary, Biller, Leah H., primary, Giannakis, Marios, primary, Ng, Kimmie, primary, Patel, Anuj K., primary, Perez, Kimberly J., primary, Singh, Harshabad, primary, Rubinson, Douglas A., primary, Schlechter, Benjamin L., primary, Andrews, Elizabeth, primary, Hannigan, Alison M., primary, Dunwell, Stanley, primary, Getchell, Zoe, primary, Raghavan, Srivatsan, primary, Wolpin, Brian M., primary, Fortier, Caroline, primary, D'Andrea, Alan D., primary, Aguirre, Andrew J., primary, Shapiro, Geoffrey I., primary, and Cleary, James M., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figures S1-S2 from A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Huffman, Brandon M., primary, Feng, Hanrong, primary, Parmar, Kalindi, primary, Wang, Junning, primary, Kapner, Kevin S., primary, Kochupurakkal, Bose, primary, Martignetti, David B., primary, Sadatrezaei, Golbahar, primary, Abrams, Thomas A., primary, Biller, Leah H., primary, Giannakis, Marios, primary, Ng, Kimmie, primary, Patel, Anuj K., primary, Perez, Kimberly J., primary, Singh, Harshabad, primary, Rubinson, Douglas A., primary, Schlechter, Benjamin L., primary, Andrews, Elizabeth, primary, Hannigan, Alison M., primary, Dunwell, Stanley, primary, Getchell, Zoe, primary, Raghavan, Srivatsan, primary, Wolpin, Brian M., primary, Fortier, Caroline, primary, D'Andrea, Alan D., primary, Aguirre, Andrew J., primary, Shapiro, Geoffrey I., primary, and Cleary, James M., primary

Published
2023
Full Text
View/download PDF

5. A Phase 1 Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-Dose Gemcitabine in Metastatic Pancreatic Adenocarcinoma Patients

Author

Huffman, Brandon M., primary, Feng, Hanrong, additional, Parmar, Kalindi, additional, Wang, Junning, additional, Kapner, Kevin S., additional, Kochupurakkal, Bose, additional, Martignetti, David B., additional, Sadatrezaei, Golbahar, additional, Abrams, Thomas A., additional, Biller, Leah H., additional, Giannakis, Marios, additional, Ng, Kimmie, additional, Patel, Anuj K., additional, Perez, Kimberly J., additional, Singh, Harshabad, additional, Rubinson, Douglas A., additional, Schlechter, Benjamin L., additional, Andrews, Elizabeth, additional, Hannigan, Alison M., additional, Dunwell, Stanley, additional, Getchell, Zoe, additional, Raghavan, Srivatsan, additional, Wolpin, Brian M., additional, Fortier, Caroline, additional, D'Andrea, Alan D., additional, Aguirre, Andrew J., additional, Shapiro, Geoffrey I., additional, and Cleary, James M., additional

Published
2023
Full Text
View/download PDF

6. Abstract CT188: A phase Ib study of sapacitabine (sapa) and olaparib (ola) in patients (pts) with BRCA1/2-mutated (BRCA1/2m) metastatic breast cancer (MBC)

Author

Lynce, Filipa, primary, Graham, Noah, additional, Kochupurakkal, Bose S., additional, Nguyen, Huy, additional, Poorvu, Philip D., additional, Attaya, Victoria, additional, Davis, Raechel, additional, Garg, Kavita, additional, Lim, Lee P., additional, Li, Mark, additional, Paweletz, Cloud P., additional, Tayob, Nabihah, additional, Shapiro, Geoffrey I., additional, and Tolaney, Sara M., additional

Published
2023
Full Text
View/download PDF

7. Abstract 6210: Combination of M1774 and niraparib can overcome ATR and PARP inhibitor resistance in BRCA1 mutated ovarian cancer models

Author

Hao, Jie, primary, Bose, Arindam, additional, Sadatrezaei, Golbahar, additional, Martignetti, David B., additional, Jiao, Yuqing, additional, da Costa, Alexandre André B., additional, Lazaro, Jean-Bernard, additional, Kochupurakkal, Bose, additional, Nguyen, Huy, additional, Parmar, Kalindi, additional, D’Andrea, Alan D., additional, and Shapiro, Geoffrey I., additional

Published
2023
Full Text
View/download PDF

8. Supplementary Data from A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

Author

Pan, Elizabeth, primary, Xie, Wanling, primary, Ajmera, Archana, primary, Araneta, Arlene, primary, Jamieson, Christina, primary, Folefac, Edmund, primary, Hussain, Arif, primary, Kyriakopoulos, Christos E., primary, Olson, Adam, primary, Parikh, Mamta, primary, Parikh, Rahul, primary, Saraiya, Biren, primary, Ivy, S. Percy, primary, Van Allen, Eliezer M., primary, Lindeman, Neal I., primary, Kochupurakkal, Bose S., primary, Shapiro, Geoffrey I., primary, and McKay, Rana R., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Data from A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

Author

Pan, Elizabeth, primary, Xie, Wanling, primary, Ajmera, Archana, primary, Araneta, Arlene, primary, Jamieson, Christina, primary, Folefac, Edmund, primary, Hussain, Arif, primary, Kyriakopoulos, Christos E., primary, Olson, Adam, primary, Parikh, Mamta, primary, Parikh, Rahul, primary, Saraiya, Biren, primary, Ivy, S. Percy, primary, Van Allen, Eliezer M., primary, Lindeman, Neal I., primary, Kochupurakkal, Bose S., primary, Shapiro, Geoffrey I., primary, and McKay, Rana R., primary

Published
2023
Full Text
View/download PDF

10. Abstract 5725: The USP1 inhibitor I-138 kills BRCA1-deficient tumor cells and overcomes PARP inhibitor resistance

Author

Da Costa, Alexandre Andre B. A., primary, Bose, Arindam, additional, Martignetti, David, additional, Ayala-Zambrano, Cecilia, additional, Ravindranathan, Ramya, additional, Sadatrezaei, Golbahar, additional, Jiao, Yuqing, additional, Kochupurakkal, Bose, additional, Nguyen, Huy, additional, Lazaro, Jean-Bernard, additional, Parmar, Kalindi, additional, Shapiro, Geoffrey I., additional, and D’Andrea, Alan D., additional

Published
2023
Full Text
View/download PDF

11. Data from A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

Author

Pan, Elizabeth, primary, Xie, Wanling, primary, Ajmera, Archana, primary, Araneta, Arlene, primary, Jamieson, Christina, primary, Folefac, Edmund, primary, Hussain, Arif, primary, Kyriakopoulos, Christos E., primary, Olson, Adam, primary, Parikh, Mamta, primary, Parikh, Rahul, primary, Saraiya, Biren, primary, Ivy, S. Percy, primary, Van Allen, Eliezer M., primary, Lindeman, Neal I., primary, Kochupurakkal, Bose S., primary, Shapiro, Geoffrey I., primary, and McKay, Rana R., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 5 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figures 1 - 6 from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 1 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 2 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

17. Data from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure Legend from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table 1 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figures 1 - 6 from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Data from A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

Author

Pan, Elizabeth, primary, Xie, Wanling, primary, Ajmera, Archana, primary, Araneta, Arlene, primary, Jamieson, Christina, primary, Folefac, Edmund, primary, Hussain, Arif, primary, Kyriakopoulos, Christos E., primary, Olson, Adam, primary, Parikh, Mamta, primary, Parikh, Rahul, primary, Saraiya, Biren, primary, Ivy, S. Percy, primary, Van Allen, Eliezer M., primary, Lindeman, Neal I., primary, Kochupurakkal, Bose S., primary, Shapiro, Geoffrey I., primary, and McKay, Rana R., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Text and Figures from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure Legend from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

24. Data from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Text and Figures from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 4 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 5 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

29. Data from NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth

Author

Bailey, Shannon T., primary, Miron, Penelope L., primary, Choi, Yoon J., primary, Kochupurakkal, Bose, primary, Maulik, Gautam, primary, Rodig, Scott. J., primary, Tian, Ruiyang, primary, Foley, Kathleen M., primary, Bowman, Teresa, primary, Miron, Alexander, primary, Brown, Myles, primary, Iglehart, J. Dirk., primary, and Biswas, Debajit K., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Table 4 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table 2 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

32. Figure S3 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

33. Figure S4 from Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Author

Do, Khanh T., primary, Kochupurakkal, Bose, primary, Kelland, Sarah, primary, de Jonge, Adrienne, primary, Hedglin, Jennifer, primary, Powers, Allison, primary, Quinn, Nicholas, primary, Gannon, Courtney, primary, Vuong, Loan, primary, Parmar, Kalindi, primary, Lazaro, Jean-Bernard, primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

Author

Keenan, Tanya E., primary, Li, Tianyu, primary, Vallius, Tuulia, primary, Guerriero, Jennifer L., primary, Tayob, Nabihah, primary, Kochupurakkal, Bose, primary, Davis, Janae, primary, Pastorello, Ricardo, primary, Tahara, Rie K., primary, Anderson, Leilani, primary, Conway, Jake, primary, He, Meng X., primary, Shannon, Erin, primary, Godin, Robert E., primary, Sorger, Peter K., primary, D'Andrea, Alan, primary, Overmoyer, Beth, primary, Winer, Eric P., primary, Mittendorf, Elizabeth A., primary, Van Allen, Eliezer M., primary, Shapiro, Geoffrey I., primary, and Tolaney, Sara M., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table S1 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

36. Figure S4 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

37. Figure S6 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

38. Figure S3 from Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Author

Do, Khanh T., primary, Kochupurakkal, Bose, primary, Kelland, Sarah, primary, de Jonge, Adrienne, primary, Hedglin, Jennifer, primary, Powers, Allison, primary, Quinn, Nicholas, primary, Gannon, Courtney, primary, Vuong, Loan, primary, Parmar, Kalindi, primary, Lazaro, Jean-Bernard, primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

39. Data from ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer

Author

Rafiei, Shahrzad, primary, Fitzpatrick, Kenyon, primary, Liu, David, primary, Cai, Mu-Yan, primary, Elmarakeby, Haitham A., primary, Park, Jihye, primary, Ricker, Cora, primary, Kochupurakkal, Bose S., primary, Choudhury, Atish D., primary, Hahn, William C., primary, Balk, Steven P., primary, Hwang, Justin H., primary, Van Allen, Eliezer M., primary, and Mouw, Kent W., primary

Published
2023
Full Text
View/download PDF

40. Figure S3 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure Legends from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

42. Figure S2 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

43. Figures S1-S3; Suppl Methods from ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer

Author

Rafiei, Shahrzad, primary, Fitzpatrick, Kenyon, primary, Liu, David, primary, Cai, Mu-Yan, primary, Elmarakeby, Haitham A., primary, Park, Jihye, primary, Ricker, Cora, primary, Kochupurakkal, Bose S., primary, Choudhury, Atish D., primary, Hahn, William C., primary, Balk, Steven P., primary, Hwang, Justin H., primary, Van Allen, Eliezer M., primary, and Mouw, Kent W., primary

Published
2023
Full Text
View/download PDF

44. Figure S2 from Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Author

Do, Khanh T., primary, Kochupurakkal, Bose, primary, Kelland, Sarah, primary, de Jonge, Adrienne, primary, Hedglin, Jennifer, primary, Powers, Allison, primary, Quinn, Nicholas, primary, Gannon, Courtney, primary, Vuong, Loan, primary, Parmar, Kalindi, primary, Lazaro, Jean-Bernard, primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Table S1 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

46. Figure S4 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

47. Figure S1 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

48. Figure S4 from Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Author

Do, Khanh T., primary, Kochupurakkal, Bose, primary, Kelland, Sarah, primary, de Jonge, Adrienne, primary, Hedglin, Jennifer, primary, Powers, Allison, primary, Quinn, Nicholas, primary, Gannon, Courtney, primary, Vuong, Loan, primary, Parmar, Kalindi, primary, Lazaro, Jean-Bernard, primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

49. Figure S7 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

50. Figure S5 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Author

Parmar, Kalindi, primary, Kochupurakkal, Bose S., primary, Lazaro, Jean-Bernard, primary, Wang, Zhigang C., primary, Palakurthi, Sangeetha, primary, Kirschmeier, Paul T., primary, Yang, Chunyu, primary, Sambel, Larissa A., primary, Färkkilä, Anniina, primary, Reznichenko, Elizaveta, primary, Reavis, Hunter D., primary, Dunn, Connor E., primary, Zou, Lee, primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Matulonis, Ursula A., primary, Liu, Joyce F., primary, D'Andrea, Alan D., primary, and Shapiro, Geoffrey I., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results